Page 67 - TI Journal 18-1

USE OF PiB FOR PET IMAGING OF AD 61

H.; O’Keefe, G.; Masters, C.L.; Rowe, C.C. Abeta 1999.
deposits in older non-demented individuals 67. Wolk, D. A.; Price, J. C.; Saxton, J. A.; Snitz, B.
with cognitive decline are indicative of pre- E.; James, J. A.; Lopez, O. L.; Aizenstein, H. J.;
clinical Alzheimer’s disease. Neuropsychologia Cohen, A. D.; Weissfeld, L. A.; Mathis, C. A.;
46(6):16881697; 2008. Klunk, W.E.; DeKosky, S.T. Amyloid imaging
65. Whitaker, C.; Eckman, C.; Almeida, C.; Feinstein, in mild cognitive impairment subtypes. Ann.
D.; Atwood, C.; Eckman, E.; Crutcher, K.; Hersh, Neurol. 65(5):557-568; 2009.
L.; Leissring, M.; LaVoie, M.; Ertekin-Taner, N.; 68. Younkin, S. G. The APP and PS1/2 mutations
Shapiro, P.; Takahashi, R.; Yamin, R.; Mansourian, linked to early onset familial Alzheimer’s disease
S.; Estus, S.; Lesné, S.; Turner, T.; Farris, W.; increase the extracellular concentration and A
Stroebel, G. Live discussion: amyloid-beta beta 1-42 (43). Rinsho Shinkeigak. 37(12):1099;
degradation: the forgotten half of Alzheimer’s 1997.
disease. 12 September 2002. J. Alzheimers Dis. 69. Ziolko, S. K.; Weissfeld, L. A.; Klunk, W. E.;
5(6):491-497; 2003. Mathis, C. A.; Hoge, J. A.; Lopresti, B. J.; Dekosky,
66. Wolf, D. S.; Gearing, M.; Snowdon, D. A.; Mori, S. T.; Price, J. C. Evaluation of voxel-based
H.; Markesbery, W. R.; Mirra, S. S. Progression methods for the statistical analysis of PIB PET
of regional neuropathology in Alzheimer disease amyloid imaging studies in Alzheimer’s disease.
and normal elderly: findings from the Nun study. Neuroimage 33(1):94-102; 2006.
Alzheimer Dis. Assoc. Disord. 13(4):226-231;